2413.01(i) Title Element in “Sequence Listing XML” [R-07.2022]

2413.01(i) Title Element in “Sequence Listing XML” [R-07.2022]

[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). Formatting representations of XML (eXtensible Markup Language) elements in this section appear different than shown in Standard ST.26, which may be accessed at: www.wipo.int /export/sites/www/standards/en/pdf/03-26-01.pdf.]

The element InventionTitle described in List of Patent Application Information Elements (reproduced in MPEP § 2413.01(f)) as a required element of the “general information” part of the “Sequence Listing XML” need not be in English. It is possible for an applicant to provide more than one InventionTitle element of the general information part in more than one language. However, when the USPTO is the Receiving Office (RO/US) for an international application, the English language is required for the InventionTitle element and any other language dependent free text element of the “Sequence Listing XML.” If non-English language is presented to RO/US for a “Sequence Listing XML,” then RO/US will transfer the international application to the International Bureau, under PCT Rule 19.4.